Cornercap Investment Counsel Inc. Sells 39,542 Shares of SIGA Technologies, Inc. (NASDAQ:SIGA)

Cornercap Investment Counsel Inc. cut its stake in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 53.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,894 shares of the company’s stock after selling 39,542 shares during the quarter. Cornercap Investment Counsel Inc.’s holdings in SIGA Technologies were worth $236,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. American Century Companies Inc. lifted its stake in shares of SIGA Technologies by 251.2% in the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock valued at $6,389,000 after buying an additional 602,091 shares in the last quarter. Denali Advisors LLC purchased a new position in SIGA Technologies during the 2nd quarter worth $1,815,000. Harbor Capital Advisors Inc. bought a new stake in shares of SIGA Technologies in the 3rd quarter worth $1,098,000. WINTON GROUP Ltd purchased a new position in SIGA Technologies during the second quarter worth about $1,052,000. Finally, AltraVue Capital LLC grew its position in SIGA Technologies by 6.6% in the 2nd quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after purchasing an additional 134,450 shares in the last quarter. 55.40% of the stock is currently owned by institutional investors and hedge funds.

SIGA Technologies Stock Up 4.0 %

SIGA stock opened at $6.18 on Tuesday. The firm has a market cap of $441.25 million, a PE ratio of 5.15 and a beta of 0.89. The business has a 50 day moving average of $7.14 and a 200-day moving average of $7.95. SIGA Technologies, Inc. has a 12-month low of $4.26 and a 12-month high of $12.83.

SIGA Technologies (NASDAQ:SIGA) last released its earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The company had revenue of $10.01 million for the quarter. On average, research analysts expect that SIGA Technologies, Inc. will post 1.01 earnings per share for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.